TIMP-1 gene polymorphism: Are genetics able to predict outcome of septic patients?

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Behnes, Michael ^a   Bertsch, Thomas ^b   Hoffmann, Ursula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Laboratory of Medicine and Transfusion Medicine Central Laboratory   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR 4; GENETIC MARKER; TIMP1 PROTEIN, HUMAN;

ACUTE HEART FAILURE; ALLELE; DISEASE COURSE; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; GENETIC RISK; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNE RESPONSE; INFECTION RESISTANCE; INTENSIVE CARE; NONHUMAN; NOTE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; SEPSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; X CHROMOSOME; BLOOD; FEMALE; GENETIC MARKER; GENETICS; MALE;

FEMALE; GENETIC MARKERS; HUMANS; MALE; POLYMORPHISM, GENETIC; SEPSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84880721376     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12799     Document Type: Note

References (15)

1. Lorente L, Martín MM, Plasencia F, Solé-Violán J, Blanquer J, Labarta L, Díaz C, Borreguero-León JM, Jiménez A, Páramo JA, Orbe J, Rodríguez JA, Salido E. The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis. Crit Care 2013, 17:R94. 10.1186/cc12739, 3706773, 23706069.
2. Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010, 14:R237. 10.1186/cc9392, 3219990, 21190579.
3. Iyer RP, Patterson NL, Fields GB, Lindsey ML. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 2012, 303:H919-H930. 10.1152/ajpheart.00577.2012, 22904159.
4. Chromek M, Tullus K, Lundahl J, Brauner A. Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation. Infect Immun 2004, 72:82-88. 10.1128/IAI.72.1.82-88.2004, 343974, 14688084.
5. Hoffmann U, Bertsch T, Dvortsak E, Liebetrau C, Lang S, Liebe V, Huhle G, Borggrefe M, Brueckmann M. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand J Infect Dis 2006, 38:867-872. 10.1080/00365540600702058, 17008230.
6. Lorente L, Martín MM, Labarta L, Díaz C, Solé-Violán J, Blanquer J, Orbe J, Rodríguez JA, Jiménez A, Borreguero-León JM, Belmonte F, Medina JC, Llimiñana MC, Ferrer-Agüero JM, Ferreres J, Mora ML, Lubillo S, Sánchez M, Barrios Y, Sierra A, Páramo JA. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care 2009, 13:R158. 10.1186/cc8115, 2784384, 19799791.
7. Skarmoutsou E, D'Amico F, Marchini M, Malaponte G, Scorza R, Mazzarino MC. Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients. Hum Immunol 2012, 73:950-953. 10.1016/j.humimm.2012.07.040, 22820628.
8. Hung KH, Hung HW, Yang HB, Lu CC, Wu JJ, Sheu BS. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection. Helicobacter 2009, 14:580-587. 10.1111/j.1523-5378.2009.00717.x, 19889076.
9. Yi YC, Chen MK, Chen LY, Ho ES, Ying TH, Wang PH, Yang SF. Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer. Clin Chim Acta 2009, 409:127-131. 10.1016/j.cca.2009.09.015, 19758569.
10. Goldbergova MP, Parenica J, Jarkovsky J, Kala P, Poloczek M, Manousek J, Kluz K, Kubkova L, Littnerova S, Tesak M, Toman O, Pavek N, Cermakova Z, Tomandl J, Vasku A, Spinar J. The association between levels of tissue inhibitor of metalloproteinase-1 with acute heart failure and left ventricular dysfunction in patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention. Genetic Test Mol Biomarkers 2012, 16:1172-1178. 10.1089/gtmb.2012.0120, 22971139.
11. Kothari N, Bogra J, Abbas H, Kohli M, Malik A, Kothari D, Srivastava S, Singh PK. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine 2013, 61:676-681. 10.1016/j.cyto.2012.11.016, 23317877.
12. Peres Wingeyer SD, Cunto ER, Nogueras CM, San Juan JA, Gomez N, de Larranaga GF. Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina. J Infect Dev Ctries 2012, 6:555-562.
13. Zhu L, Li X, Miao C. Lack of association between TLR4 Asp299Gly and Thr399Ile polymorphisms and sepsis susceptibility: a meta-analysis. Gene 2012, 501:213-218. 10.1016/j.gene.2012.04.027, 22537674.
14. Lauhio A, Hastbacka J, Pettila V, Tervahartiala T, Karlsson S, Varpula T, Varpula M, Ruokonen E, Sorsa T, Kolho E. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011, 64:590-594. 10.1016/j.phrs.2011.06.019, 21742038.
15. Zhu S, Ashok M, Li J, Li W, Yang H, Wang P, Tracey KJ, Sama AE, Wang H. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009, 15:275-282. 2707519, 19593412.